SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-006384
Filing Date
2019-02-07
Accepted
2019-02-07 17:27:22
Documents
3
Period of Report
2019-02-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-4137_18k.htm 8-K 26843
2 EX-10.1 a19-4137_1ex10d1.htm EX-10.1 73906
3 EX-10.2 a19-4137_1ex10d2.htm EX-10.2 15829
  Complete submission text file 0001104659-19-006384.txt   117921
Mailing Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104
Business Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35890 | Film No.: 19576163
SIC: 2834 Pharmaceutical Preparations